Julie Bynum
Papers
1
Total Citations
4
H-Index
1
About
Julie Bynum is a leading health services researcher whose work focuses on the intersection of cancer care delivery, treatment patterns, and the impact of new technologies on clinical practice. Her research examines how the adoption of advanced therapies—such as stereotactic body radiation therapy (SBRT) for prostate cancer—shifts treatment paradigms, potentially altering the balance between aggressive intervention and active surveillance. Bynum’s major contributions include elucidating the real-world consequences of technological diffusion, demonstrating that new treatments may not simply replace older ones but can expand the pool of patients receiving any therapy. Her most-cited paper, “The Influence of Stereotactic Body Radiation Therapy Adoption on Prostate Cancer Treatment Patterns” (2019, 4 citations), uses SEER data to reveal how SBRT adoption influences treatment choices, raising critical questions about overdiagnosis and overtreatment. Though her citation counts are modest, her work is highly influential in health policy and oncology circles, informing guidelines and reimbursement decisions. Bynum’s research is essential for understanding how innovation shapes patient care, making her a key voice in the ongoing debate about value and appropriateness in cancer treatment.
Research Focus
Key Achievements
Top Papers
- 1